The protective effect of icariin and phosphorylated icariin against LPS-induced intestinal goblet cell dysfunction
The protective effect of icariin and phosphorylated icariin against LPS-induced intestinal goblet cell dysfunction
复制标题
淫羊藿苷和磷酸化淫羊藿苷对脂多糖诱导的肠杯状细胞功能障碍的保护作用
DOI:
10.1177/1753425919867746
复制
发表时间:
2019-08
期刊:
影响因子:
3.2
通讯作者:
Zili Wang
中科院分区:
文献类型:
--
作者:
Wen Xiong;Haoyue Ma;Zhu Zhang;Meilan Jin;Jian Wang;Yuwei Xu;Zili Wang
In this study, we used LS174T cells as a model to investigate the protective effects of icariin and phosphorylated icariin on LPS-induced goblet cell dysfunction. Our results indicated that icariin and phosphorylated icariin increased the cell viability and decreased lactate dehydrogenase activity in LPS-treated LS174T cells. Icariin and phosphorylated icariin attenuated LPS-induced changes in mucin 2 synthesis and secretion. Besides, Icariin and phosphorylated icariin reduced the levels of ROS, MDA, and H2O2 and increased the activity of SOD, GPx, CAT, and T-AOC in LPS-treated LS174T cells. Moreover, the levels of IL-1β, IL-6, IL-8, and TNF-α were reduced in the Icariin and phosphorylated icariin group. Furthermore, Icariin and phosphorylated icariin decreased gene abundance or enzyme activity of Bip, XBP1, GRP78, CHOP, caspase-3, and caspase-4 in LPS-treated LS174T cells. Our data suggest that Icariin and phosphorylated icariin effectively attenuate LPS-induced intestinal goblet cell function damage through regulating oxidative stress, inflammation, apoptosis, and mucin expression.
登录
查看更多内容
影响因子:
4.5
作者:
Qun Zeng;Huilan Yi;Liqun Huang;Quan An;Hong Wang
通讯作者:
Qun Zeng;Huilan Yi;Liqun Huang;Quan An;Hong Wang
DOI:
10.3390/molecules23051151
发表时间:
2018-05-11
期刊:
Molecules (Basel, Switzerland)
影响因子:
--
作者:
Morozov V;Borkowski J;Hanisch FG
通讯作者:
Hanisch FG
影响因子:
1.9
作者:
Chutkan, RK
通讯作者:
Chutkan, RK
影响因子:
5.4
作者:
Polissi A;Sperandeo P
通讯作者:
Sperandeo P
DOI:
10.15403/jgld.2014.1121.253.niv
发表时间:
2016-09
期刊:
Journal of gastrointestinal and liver diseases : JGLD
影响因子:
--
作者:
Y. Niv
通讯作者:
Y. Niv